About Us

Through innovating in knowledge creation and retrieval software, the mission of SemanTx Life Sciences is to raise the quality and productivity of drug discovery and marketing.

SemanTx Life Sciences builds the Semantic Knowledge Indexing Platform (SKIP). SKIP is an ontology-based knowledge-indexing engine, which searches information with better Precision and Recall than search engines, and reduces the burden of information maintenance.

SemanTx Life Sciences holds numerous patents on knowledge assembly and retrieval, and is actively expanding its intellectual property portfolio and product base. The idea for our products derives from work for the National Institutes of Health (NIH), under an SBIR grant to improve the understanding of medical research.

SemanTx Life Sciences is a private company, funded by established investors in technology and the life sciences.

Company Founders

Michael Belanger is the President and Co-Founder of SemanTx Life Sciences. Belanger is well known for his contributions to enterpreneurship and innovation.
Contact: mbelanger@semantxls.com

Professor Ken Baclawski is the Chief Technical Architect and Co-Founder of SemanTx Life Sciences. Professor Baclawski is the inventor of our patented indexing method, and is involved in consulting on knowledge management and the Semantic web, including work on the Defense Agencies Markup Language (DAML). Professor Baclawski is a tenured professor of Computer Sciences at Northeastern University.
Contact: kbaclwaski@jarg.com

SemanTx Life Sciences is a wholly owned division of Jarg Corporation, based in Waltham Massachusetts. Jarg was founded to provide a new approach to knowledge management and retrieval, across all industries.